Brickell Biotech Inc (NASDAQ:BBI)
| 0.8284 Delayed Data As of Aug 13 |  -0.0612 / -6.88%Today’s Change | 0.71 Today|||52-Week Range 6.51 | -44.77% Year-to-Date |
Latest BBI News | Press Releases
| Brickell Biotech, Inc. (BBI) CEO Robert Brown on Q2 2020 Results - Earnings Call Transcript Aug 12 / Seeking Alpha - Paid Partner Content | Brickell Biotech reports Q2 results Aug 12 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 0.89 |
| Today’s open | 0.84 |
| Day’s range | 0.81 - 0.84 |
| Volume | 755,897 |
| Average volume (3 months) | 1,281,574 |
| Market cap | $25.2M |
Data as of 3:57pm ET, 08/13/2020
Growth & Valuation
| Earnings growth (last year) | +13.62% |
| Earnings growth (this year) | +92.22% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +388.10% |
| P/E ratio | NM |
| Price/Sales | 0.57 |
| Price/Book | 1.04 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SLSSellas Life Sciences... | -0.04 | -1.20% |
| ---- | ||
| ADILAdial Pharmaceutical... | +0.02 | +1.24% |
| SXTCChina SXT Pharmaceut... | -0.01 | -3.73% |
Data as of 3:59pm ET, 08/13/2020
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $7.9M |
| Annual profit (last year) | -$23.9M |
| Net profit margin | -301.59% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Boulder, Colorado |
Forecasts
